Infusion Therapy Devices Market Forecast 2026–2035 Reflecting Expansion Opportunities Across Industries

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Infusion Therapy Devices Market Evolve From 2026 To 2030?

The infusion therapy devices market has experienced significant expansion in recent years. This market is projected to increase from $13.33 billion in 2025 to $14.74 billion in 2026, showing a compound annual growth rate (CAGR) of 10.5%. The historical growth in this sector is attributable to the rising prevalence of chronic diseases, an uptick in hospital admissions needing infusion therapy, the broadening of oncology and diabetes treatments, the growing application of intravenous drug delivery, and enhanced availability of infusion devices.

The infusion therapy devices market size is anticipated to expand significantly in the coming years. It is projected to reach $21.82 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 10.3%. The projected growth during this period is largely attributable to the increasing demand for home healthcare services, the growing adoption of connected medical devices, the expansion of personalized medicine delivery, a greater focus on reducing medication errors, and increased investments in smart hospital infrastructure. Moreover, significant trends expected in the forecast period include the rising adoption of smart infusion pumps, increasing demand for portable and ambulatory infusion devices, expanding integration of dose error reduction systems, the broader expansion of home-based infusion therapy, and an enhanced emphasis on patient safety and monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

What Key Drivers Are Influencing The Growth Of The Infusion Therapy Devices Market?

The growing incidence of chronic diseases is anticipated to drive the expansion of the infusion therapy devices market in the future. These are defined as health conditions enduring for a minimum of one year, necessitating continuous medical management or restricting daily activities. The rise in chronic disease prevalence stems from factors like unhealthy lifestyle decisions, inactive routines, poor dietary habits, and environmental impacts, alongside a surge in risk elements including obesity, smoking, and stress. Infusion therapy devices play a crucial role in managing chronic diseases by facilitating the accurate and regulated administration of medications and fluids directly into the circulatory system. This ensures dependable and effective treatment for various conditions such as diabetes, autoimmune disorders, and cancer, ultimately leading to better patient results, increased ease of use, and fewer hospitalizations. For example, data from January 2023 by the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, forecasts that by 2050, the population aged 50 years and above with at least one chronic illness will see a 99.5% increase, climbing from 71.522 million in 2020 to 142.66 million. Consequently, the growing occurrence of chronic diseases is a key driver for the expansion of the infusion therapy devices market.

Which Segment Areas Are Covered In The Infusion Therapy Devices Market Analysis?

The infusion therapy devices market covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors

2) By Mobility: Portable Infusion Pumps, Stationary Pumps

3) By Application: Oncology, Diabetes, Pain Management, Other Applications

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps

2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters

3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas

4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

What Key Developments And Trends Are Impacting The Infusion Therapy Devices Market?

Leading companies in the infusion therapy devices market are concentrating on developing innovative solutions, such as pressure-enabled drug delivery (PEDD) technology, to improve the treatment of liver and pancreatic tumors. Pressure-enabled drug delivery (PEDD) is a drug delivery technology that uses pressure to enhance the infusion of therapeutic agents into tissues or organs, particularly where conventional methods may face challenges. For instance, in November 2024, TriSalus Life Sciences, a US-based medical technology company, launched the TriNav LV Infusion System and TriGuide Guiding Catheters, thereby expanding its pressure-enabled drug delivery (PEDD) portfolio to optimize therapeutic delivery, enhance treatment options, and potentially improve outcomes for patients. The TriNav LV Infusion System offers unique features such as its compatibility with larger blood vessels (3.5 to 5.0 mm), expanding the use of TriSalus’ Pressure-Enabled Drug Delivery (PEDD) technology to a broader patient population. This launch extends PEDD device compatibility from 1.5 mm to 5.0 mm vessels, providing interventional radiologists with more treatment options. TriGuide Guiding Catheters feature a larger inner diameter, a lubricious lining, and a reverse curve design for easier femoral access and improved procedural efficiency. Early users have reported a 97% satisfaction rate, highlighting the system’s effectiveness and ease of use in oncology treatments.

Which Global Companies Are Actively Competing In The Infusion Therapy Devices Market?

Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., Smiths Medical, Teleflex Incorporated

Read the full infusion therapy devices market report here:

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Infusion Therapy Devices Market?

North America was the largest region in the infusion therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Infusion Therapy Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp

Browse Through More Reports Similar to the Global Infusion Therapy Devices Market 2026, By The Business Research Company

Cigarette Filters Market Report 2026

https://www.thebusinessresearchcompany.com/report/cigarette-filters-global-market-report

Bag Filter Market Report 2026

https://www.thebusinessresearchcompany.com/report/bag-filter-global-market-report

Filters Market Report 2026

https://www.thebusinessresearchcompany.com/report/filters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795